TY -的T1 hospitalisatio速度和持续时间n for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01677-2018 VL - 53 IS - 2 SP - 1801677 AU - Mastroiacovo, Daniela AU - Dentali, Francesco AU - di Micco, Pierpaolo AU - Maestre, Ana AU - Jiménez, David AU - Soler, Silvia AU - Sahuquillo, Joan Carles AU - Verhamme, Peter AU - Fidalgo, Ángeles AU - López-Sáez, Juan Bosco AU - Skride, Andris AU - Monreal, Manuel A2 - , Y1 - 2019/02/01 UR - //www.qdcxjkg.com/content/53/2/1801677.abstract N2 - The latest guidelines suggest considering home treatment or early hospital discharge in low-risk mortality pulmonary embolism (PE) patients, identified through widely validated clinical prediction rules [1, 2]. Nevertheless, it is still not clear if these patients are really treated on an outpatient basis in clinical practice.Real-life data from the RIETE study suggest only a few patients with pulmonary embolism at low risk of complications were treated at home or hospitalised for ≤5 days. Management of PE appeared quite variable in different countries. http://ow.ly/o2b230mD8EYWe express our gratitude to Sanofi Spain for supporting this Registry with an unrestricted educational grant. We also express our gratitude to Bayer Pharma AG for supporting this Registry. Bayer Pharma AG's support was limited to the part of RIETE outside Spain, which accounts for a 24.01% of the total patients included in the RIETE Registry. We also thank the RIETE Registry Coordinating Centre, S & H Medical Science Service, for their quality control data, logistic and administrative support. ER -